Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech

Country: Kesatuan Eropah

Bahasa: Croat

Sumber: EMA (European Medicines Agency)

Beli sekarang

Download Laporan Penilaian Awam (PAR)
15-09-2017

Bahan aktif:

ljudskog IgG1 monoklonskog protutijela specifična za ljudski interleukina-1 alfa

Boleh didapati daripada:

XBiotech Germany GmbH

Kod ATC:

L01

INN (Nama Antarabangsa):

human IgG1 monoclonal antibody specific for human interleukin-1 alpha

Kumpulan terapeutik:

Antineoplastična sredstva

Kawasan terapeutik:

Kolorektalne neoplazme

Tanda-tanda terapeutik:

Liječenje метастатического raka debelog crijeva .

Status kebenaran:

odbijen

Dokumen dalam bahasa lain

Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Czech 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Greek 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Inggeris 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Itali 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Malta 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Poland 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Romania 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Finland 15-09-2017
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 15-09-2017